These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37076661)

  • 1. Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
    Ohata K; Sugaya T; Nguyen HN; Hatanaka Y; Uno K; Tohma M; Oikawa T; Nagabukuro H; Kuniyeda K; Kamijo-Ikemori A; Suzuki-Kemuriyama N; Nakae D; Noiri E; Miyajima K
    Nephrology (Carlton); 2023 Jun; 28(6):345-355. PubMed ID: 37076661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure.
    Wakisaka Y; Inai K; Sato M; Harada G; Asagai S; Shimada E
    Heart Vessels; 2023 Mar; 38(3):371-380. PubMed ID: 36169710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.
    Yanishi M; Kinoshita H
    BMC Nephrol; 2022 Mar; 23(1):125. PubMed ID: 35361160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery.
    Schaub JA; Garg AX; Coca SG; Testani JM; Shlipak MG; Eikelboom J; Kavsak P; McArthur E; Shortt C; Whitlock R; Parikh CR;
    Kidney Int; 2015 Sep; 88(3):576-83. PubMed ID: 25830762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease.
    Katayama M; Ohata K; Miyazaki T; Katayama R; Wakamatsu N; Ohno M; Yamashita T; Oikawa T; Sugaya T; Miyazaki M
    J Vet Intern Med; 2020 Mar; 34(2):761-769. PubMed ID: 32087614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
    Katoh H; Nozue T; Kimura Y; Nakata S; Iwaki T; Kawano M; Kawashiri MA; Michishita I; Yamagishi M
    Heart Vessels; 2014 Mar; 29(2):191-7. PubMed ID: 23604313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
    Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y
    Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
    Naruse H; Ishii J; Takahashi H; Kitagawa F; Nishimura H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Hayashi M; Sarai M; Watanabe E; Izawa H; Ozaki Y
    Crit Care; 2018 Aug; 22(1):197. PubMed ID: 30119691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of contrast-induced acute kidney injury by early post-procedural analysis of urinary biomarkers and intra-renal Doppler flow indices in patients undergoing coronary angiography.
    Wybraniec MT; Chudek J; Bożentowicz-Wikarek M; Mizia-Stec K
    J Interv Cardiol; 2017 Oct; 30(5):465-472. PubMed ID: 28685874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the excretion levels of traditional and novel urinary biomarkers of nephrotoxicity in rats.
    Tsuji S; Sugiura M; Tsutsumi S; Yamada H
    J Toxicol Sci; 2017; 42(5):615-627. PubMed ID: 28904297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.
    Parikh CR; Thiessen-Philbrook H; Garg AX; Kadiyala D; Shlipak MG; Koyner JL; Edelstein CL; Devarajan P; Patel UD; Zappitelli M; Krawczeski CD; Passik CS; Coca SG;
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1079-88. PubMed ID: 23599408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair.
    Obata Y; Kamijo-Ikemori A; Ichikawa D; Sugaya T; Kimura K; Shibagaki Y; Tateda T
    J Anesth; 2016 Feb; 30(1):89-99. PubMed ID: 26585768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.
    Connolly M; Kinnin M; McEneaney D; Menown I; Kurth M; Lamont J; Morgan N; Harbinson M
    QJM; 2018 Feb; 111(2):103-110. PubMed ID: 29069419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of urinary liver fatty acid-binding protein in assessing severity of brain trauma and predicting acute kidney injury].
    Wu GY; Zhuang K; Liu Y; Wang ZF
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1527-1530. PubMed ID: 27881344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
    Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
    Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of tubular and podocyte biomarkers in acute kidney injury.
    Matsui K; Kamijo-Ikemori A; Hara M; Sugaya T; Kodama T; Fujitani S; Taira Y; Yasuda T; Kimura K
    Clin Exp Nephrol; 2011 Apr; 15(2):220-5. PubMed ID: 21153750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-FABP: A novel biomarker of kidney disease.
    Xu Y; Xie Y; Shao X; Ni Z; Mou S
    Clin Chim Acta; 2015 May; 445():85-90. PubMed ID: 25797895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating AST, H-FABP, and NGAL are early and accurate biomarkers of graft injury and dysfunction in a preclinical model of kidney transplantation.
    Jochmans I; Lerut E; van Pelt J; Monbaliu D; Pirenne J
    Ann Surg; 2011 Nov; 254(5):784-91; discussion 791-2. PubMed ID: 21997818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.